Javier Mataix Díaz

2PUBLICATIONS
13CO-AUTHORS
Nanotoxicology, health and safetyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 27, 2026
Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS).

|Dec 05, 2025
Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study.

Javier Mataix Díaz, Sergio Santos Alarcón, Isabel Belinchón Romero

Pageof 1

Frequent Collaborators

2 joint publications

Ricardo Ruíz-Villaverde

1 joint publications

Mar Llamas-Velasco

1 joint publications

Mercedes Hospital

1 joint publications

Raquel Rivera